Fractyl Health appoints Conaway to board of directors

Fractyl Health announced the appointment of Samuel Conaway to its Board of Directors. Conaway’s background in the commercialization of medical technologies and leadership in new product launches will provide valuable insight and experience as Fractyl Health advances through pivotal clinical studies for T2D and weight loss maintenance and continues its ongoing pilot launch and real-world registry study of Revita in Germany.